Skip to content

Roland Griffiths: innovative psychedelics researcher

Joanne Silberner

BMJ November 16, 2023 DOI: 10.1136/bmj.p2703 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Peer reviewed
Key points Roland Griffiths, a key figure in psychedelic research, encouraged his mentee to treat his terminal cancer as an opportunity to feel.

Abstract

at the age of 77, was an American psychopharmacologist widely credited with reviving the study of psychedelic drugs."He was almost the opposite of what I imagined a psychedelic researcher would be like," said Nassim Assefi, who curated a talk Griffiths gave in 2015."He was serious, gentle, and had a straight laced appearance, with a deeply calm, spiritual sense about him."When Griffiths learnt his stage 4 colon cancer was likely to be terminal, he told his mentee David Yaden that Yaden should take his mentor's impending death "as an opportunity to feel